Search Results for "Biosoft Pharma"

14:39 EDT 1st September 2014 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

OxyContin

OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Devices - medical, biotech, pharma

A medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery.  Medical devices act by physical, mechanical, thermal, physico-chemical or chemic...

Matching News

Agilent Technologies and PREMIER Biosoft Couple Hardware-Software Platforms to Advance Glycomics Research

Complementary Technologies Maximize Analytical Capabilities, Enable Researchers to Advance Discovery in Cancer, Other Complex Diseases Agilent Technologies, Inc. (NYSE:A) and...

Agilent Tech and PREMIER Biosoft Couple Hardware-Software Platforms to Advance Glycomics Research

Complementary technologies maximise analytical capabilities, enable researchers to advance discovery in cancer, other complex diseases.

Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma

LONDON, August 6, 2014 /PRNewswire/ --read more

Pharma Summit: Rethinking the future – new business models for pharma

The way pharma works needs to change with an increasing focus on collaborations, sharing data and access to medicines, according to a panel discussion at The Economist’s Pharma Summit in London yest...

Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma

LONDON, July 23, 2014 /PRNewswire/ -- On Tuesday, July 22, 2014, the NASDAQ Composite ended at 4,456.02, up 0.71%, the Dow Jones Industrial Average finished the day 0.36% higher at 17,113.54, and ...

Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma

LONDON, August 6, 2014 /PRNewswire/ -- On Tuesday, August 5, 2014, the NASDAQ Composite ended at 4,352.84, down 0.71%, the Dow Jones Industrial Average declined 0.84%, to finish the day at 16,429....

Download: The future of Pharma

At DigiPharm 2013, we were joined by Professor Brian D. Smith, author of “The Future of Pharma” who gave an in-depth presentation on how pharma has evolved and where it is heading. What sc...

Pharma Stocks on our Radar -- Research on AVANIR Pharma, Zoetis, Salix Pharma, and Jazz Pharma

LONDON, April 10, 2014 /PRNewswire/ -- The trading session on Wednesday, April 09, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,437.18, up 1.11% and the NASDAQ ...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement